Request for Covid-19 Impact Assessment of this Report
Sales, means the sales volume of Prostacyclin
Revenue, means the sales value of Prostacyclin
This report studies sales (consumption) of Prostacyclin in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Actelion Pharmaceuticals Ltd.
United Therapeutics Corporation
Gilead sciences
Bayer AG
SteadyMed Ltd.
GlaxoSmithKline plc
Pfizer Inc.
Reata Pharmaceuticals Inc.
Arena Pharmaceuticals Inc.
Merck & Co. Inc
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III
Split by applications, this report focuses on sales, market share and growth rate of Prostacyclin in each application, can be divided into
Health care
Clinic
Hospital
United States Prostacyclin Market Report 2016
1 Prostacyclin Overview
1.1 Product Overview and Scope of Prostacyclin
1.2 Classification of Prostacyclin
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prostacyclin
1.3.1 Health care
1.3.2 Clinic
1.3.3 Hospital
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Prostacyclin (2011-2021)
1.4.1 USA Prostacyclin Sales and Growth Rate (2011-2021)
1.4.2 USA Prostacyclin Revenue and Growth Rate (2011-2021)
2 USA Prostacyclin Competition by Manufacturers
2.1 USA Prostacyclin Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Prostacyclin Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Prostacyclin Average Price by Manufactures (2015 and 2016)
2.4 Prostacyclin Market Competitive Situation and Trends
2.4.1 Prostacyclin Market Concentration Rate
2.4.2 Prostacyclin Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Prostacyclin Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Prostacyclin Sales and Market Share by Type (2011-2016)
3.2 USA Prostacyclin Revenue and Market Share by Type (2011-2016)
3.3 USA Prostacyclin Price by Type (2011-2016)
3.4 USA Prostacyclin Sales Growth Rate by Type (2011-2016)
4 USA Prostacyclin Sales (Volume) by Application (2011-2016)
4.1 USA Prostacyclin Sales and Market Share by Application (2011-2016)
4.2 USA Prostacyclin Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Prostacyclin Manufacturers Profiles/Analysis
5.1 Actelion Pharmaceuticals Ltd.
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prostacyclin Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Actelion Pharmaceuticals Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 United Therapeutics Corporation
5.2.2 Prostacyclin Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Gilead sciences
5.3.2 Prostacyclin Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Gilead sciences Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Bayer AG
5.4.2 Prostacyclin Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 SteadyMed Ltd.
5.5.2 Prostacyclin Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 SteadyMed Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 GlaxoSmithKline plc
5.6.2 Prostacyclin Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 GlaxoSmithKline plc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Pfizer Inc.
5.7.2 Prostacyclin Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Pfizer Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 Reata Pharmaceuticals Inc.
5.8.2 Prostacyclin Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 Reata Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Arena Pharmaceuticals Inc.
5.9.2 Prostacyclin Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Arena Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Merck & Co. Inc
5.10.2 Prostacyclin Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Merck & Co. Inc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
6 Prostacyclin Manufacturing Cost Analysis
6.1 Prostacyclin Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostacyclin
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Prostacyclin Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostacyclin Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Prostacyclin Market Forecast (2016-2021)
10.1 USA Prostacyclin Sales, Revenue Forecast (2016-2021)
10.2 USA Prostacyclin Sales Forecast by Type (2016-2021)
10.3 USA Prostacyclin Sales Forecast by Application (2016-2021)
10.4 Prostacyclin Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
Figure Picture of Prostacyclin
Table Classification of Prostacyclin
Figure USA Sales Market Share of Prostacyclin by Type in 2015
Table Application of Prostacyclin
Figure USA Sales Market Share of Prostacyclin by Application in 2015
Figure Health care Examples
Figure Clinic Examples
Figure Hospital Examples
Figure USA Prostacyclin Sales and Growth Rate (2011-2021)
Figure USA Prostacyclin Revenue and Growth Rate (2011-2021)
Table USA Prostacyclin Sales of Key Manufacturers (2015 and 2016)
Table USA Prostacyclin Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostacyclin Sales Share by Manufacturers
Figure 2016 Prostacyclin Sales Share by Manufacturers
Table USA Prostacyclin Revenue by Manufacturers (2015 and 2016)
Table USA Prostacyclin Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Prostacyclin Revenue Share by Manufacturers
Table 2016 USA Prostacyclin Revenue Share by Manufacturers
Table USA Market Prostacyclin Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Prostacyclin Average Price of Key Manufacturers in 2015
Figure Prostacyclin Market Share of Top 3 Manufacturers
Figure Prostacyclin Market Share of Top 5 Manufacturers
Table USA Prostacyclin Sales by Type (2011-2016)
Table USA Prostacyclin Sales Share by Type (2011-2016)
Figure USA Prostacyclin Sales Market Share by Type in 2015
Table USA Prostacyclin Revenue and Market Share by Type (2011-2016)
Table USA Prostacyclin Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostacyclin by Type (2011-2016)
Table USA Prostacyclin Price by Type (2011-2016)
Figure USA Prostacyclin Sales Growth Rate by Type (2011-2016)
Table USA Prostacyclin Sales by Application (2011-2016)
Table USA Prostacyclin Sales Market Share by Application (2011-2016)
Figure USA Prostacyclin Sales Market Share by Application in 2015
Table USA Prostacyclin Sales Growth Rate by Application (2011-2016)
Figure USA Prostacyclin Sales Growth Rate by Application (2011-2016)
Table Actelion Pharmaceuticals Ltd. Basic Information List
Table Actelion Pharmaceuticals Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Actelion Pharmaceuticals Ltd. Prostacyclin Sales Market Share (2011-2016)
Table United Therapeutics Corporation Basic Information List
Table United Therapeutics Corporation Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table United Therapeutics Corporation Prostacyclin Sales Market Share (2011-2016)
Table Gilead sciences Basic Information List
Table Gilead sciences Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Gilead sciences Prostacyclin Sales Market Share (2011-2016)
Table Bayer AG Basic Information List
Table Bayer AG Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer AG Prostacyclin Sales Market Share (2011-2016)
Table SteadyMed Ltd. Basic Information List
Table SteadyMed Ltd. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table SteadyMed Ltd. Prostacyclin Sales Market Share (2011-2016)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline plc Prostacyclin Sales Market Share (2011-2016)
Table Pfizer Inc. Basic Information List
Table Pfizer Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Pfizer Inc. Prostacyclin Sales Market Share (2011-2016)
Table Reata Pharmaceuticals Inc. Basic Information List
Table Reata Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Reata Pharmaceuticals Inc. Prostacyclin Sales Market Share (2011-2016)
Table Arena Pharmaceuticals Inc. Basic Information List
Table Arena Pharmaceuticals Inc. Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Arena Pharmaceuticals Inc. Prostacyclin Sales Market Share (2011-2016)
Table Merck & Co. Inc Basic Information List
Table Merck & Co. Inc Prostacyclin Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co. Inc Prostacyclin Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostacyclin
Figure Manufacturing Process Analysis of Prostacyclin
Figure Prostacyclin Industrial Chain Analysis
Table Raw Materials Sources of Prostacyclin Major Manufacturers in 2015
Table Major Buyers of Prostacyclin
Table Distributors/Traders List
Figure USA Prostacyclin Production and Growth Rate Forecast (2016-2021)
Figure USA Prostacyclin Revenue and Growth Rate Forecast (2016-2021)
Table USA Prostacyclin Production Forecast by Type (2016-2021)
Table USA Prostacyclin Consumption Forecast by Application (2016-2021)
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...